Rhonda Farnum
SVP, COMM & MEDICAL AFFAIRS · 3 filings · Latest: May 20, 2026
Theravance Biopharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TBPH | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | May 20, 2026 | Tax Withholding | $16.55 | 5,678 | $94.0K | 245,771 | |
TBPH | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Apr 1, 2026 | Grant/Award | $0.00 | 18,750 | — | 251,449 | |
TBPH | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Mar 16, 2026 | Sale | $13.96 | 31,067 | $433.6K | 232,699 |